Investigation of the alcohol, smoking, and substance involvement screening test (the ASSIST) version 3.0 in pregnancy

Addictive Disorders and their Treatment

Volumn 12, Issue 3, 2013, Pages 123-135

  Hotham, Elizabeth ^a   Ali, Robert ^b,c   White, Jason ^a   Sullivan, Thomas ^c   Robinson, Jeffrey ^d  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b WHO Collaborating Centre   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d Drug and Alcohol Services of South Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; NICOTINE;

ALCOHOL SMOKING AND SUBSTANCE INVOLVEMENT SCREENING TEST; ARTICLE; AUSTRALIA; FEMALE; FETUS RISK; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SUBSTANCE ABUSE;

EID: 84883450894     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e3182636904     Document Type: Article

References (82)

1. World Health Organization (WHO). The World Health Report 2002: Reducing Risks Promoting Healthy Life. Geneva: World Health Organization; 2008.
2. World Health Organization. Gender and Tobacco Control: A Policy Brief. Geneva: World Health Organization; 2007.
3. Hitchman SC, Fong GT. Gender empowerment and female-to-male smoking prevalence rates. Bull World Health Organ. 2011;89:195-202.
4. Rogers J. Tobacco and pregnancy. Reprod Toxicol. 2009;28:152-160.
5. Rogers JM. Tobacco and pregnancy: overview of exposures and effects. Birth Defects Res C Embryo Today. 2008;84:1-15.
6. Sokol RJ, Miller SI, Martier S. Identifying the alcohol abusing obstetric/gynecologic patient: a practical approach. Alcohol Health Res World. 1980;4:3 6-40.
7. Makarechian N, Agro KA, Devlin JW, et al. Association between moderate alcohol consumption during pregnancy and spontaneous abortion, stillbirth and premature birth: a meta-analysis. Can J Clin Pharmacol. 1998;5:169-176.
8. Fergusson DM, Horwood LJ, Northstone K, et al. ALSPAC Study Team. Maternal use of cannabis and pregnancy outcome. BJOG. 2002;109:21-27.
9. Beratis NG, Varvarigou A, Christophidou M, et al. Cord alpha-fetoprotein concentrations in term newborns of smoking mothers. Eur J Pediatr. 1999;158:583-588.
10. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20:115-126.
11. Lemoine P. The history of alcoholic fetopathies. J FAS Int. 2003;1:e2 Available at: http://www.motherisk. org/JFAS-documents/History-Alcoholic- Fetopathies. pdf. Accessed July 5, 2012.
12. Burd L. Fetal alcohol syndrome. Addict Biol. 2004;9:115-118.
13. Park B, Gibbons HM, Mitchell MD, et al. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta. 2003;24:990-995.
14. Sun X, Dey SK. Aspects of endocannabinoid signaling in peri-implantation biology. Mol Cell Endocrinol. 2008;286:(1-2 suppl 1):S3-S11.
15. Slotkin TA, Ryde IT, Seidler FJ. Additive and synergistic effects of fetal nicotine and dexamethasone exposure on cholinergic synaptic function in adolescence and adulthood: implications for the adverse consequences of maternal smoking and pharmacotherapy of preterm delivery. Brain Res Bull. 2010;81:552-560.
16. Barker D. Human Growth and Cardiovascular Disease. in NestléNutr Workshop Ser Pediatr Program: The Window of Opportunity: Pre-Pregnancy to 24 Months of Age. Basel: Nestec Ltd., Vevey/S. Karger AG; 2008.
17. Chiriboga CA. Fetal alcohol and drug effects. Neurologist. 2003;9:267-279.
18. Streissguth A. Offspring effects of prenatal alcohol exposure from birth to 25 years: The Seattle Prospective Longitudinal Study. J Clin Psychol Med Settings. 2007;14:81-101.
19. Fried P, Watkinson B, Gray R. Differential effects on cognitive functioning in 9-to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 1998;20:293-306.
20. Pickett KE, Rathouz PJ, Kasza K, et al. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol. 2005;19: 368-376.
21. Conigrave KM, Saunders JB, Whitfield JB. Traditional markers of excessive alcohol use. Addiction. 2003;98:(suppl 2):31-43.
22. Humeniuk R, Ali R, Babor TF, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103:1039-1047.
23. Ostrea EM Jr, Knapp DK, Romero A, et al. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr. 1994;124: 471-476.
24. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989;160:863-868.
25. Chang G. Alcohol screening instruments for pregnant women. Alcohol Res Health. 2001;25: 204-209.
26. Russell M. New assessment tools for risk drinking during pregnancy. Alcohol Res Health. 1994;18: 55-61.
27. Kharrazi M, Epstein D, Hopkins B. Evaluation of four maternal smoking questions. Public Health Rep. 1999;114:60-69.
28. Project Team Mercy Hospital for Women Southern Health and Women's and Children's Health, Three Centres Consensus Guidelines on Antenatal Care. Melbourne: Mercy Hospital for Women, Southern Health Service and Women's and Children's Health Service; 2001.
29. Albrecht SA, Cornelius MD, Braxter B, et al. An assessment of nicotine dependence among pregnant adolescents. J Subst Abuse Treat. 1999;16:337-344.
30. Hotham E, Gilbert A, Atkinson EA. A randomisedcontrolled pilot study using nicotine patches with pregnant women. Addict Behav. 2006;31:641-648.
31. Manwell L, Fleming M, Mundt MP. Treatment of problem alcohol use in women of childbearing age: results of a brief intervention trial. Alcohol Clin Exp Res. 2000;24:1517-1524.
32. Project Choices Research Group. . Alcohol-exposed pregnancy: characteristics associated with risk. Am J Prev Med. 2002;23:166-173.
33. Savage C, Wray J, Ritchey PN. Measurement of maternal alcohol consumption in a pregnant population. Subst Abuse. 2002;23:211-214.
34. Dum M, Sobell LC, Sobell M, et al. A quick drinking screen for identifying women at risk for an alcohol-exposed pregnancy. Addict Behav. 2009;34: 714-716.
35. Rodgers B, Lee R. Drugabuse. In: Burrow G, Ferris T, eds. Medical Complications During Pregnancy. Philadelphia: WB Saunders Company. 1988;570-581.
36. Corse SJ, Smith M. Reducing substance abuse during pregnancy discriminating among levels of response in a prenatal setting. J Subst Abuse Treat. 1998;15: 457-467.
37. Langer A, Nigenda G, Romero M. Conceptual bases and methodology for the evaluation of women's and providers' perception of the quality of antenatal care in the WHO Antenatal Care Randomised Controlled Trial. Paediatr Perinat Epidemiol. 1998; 12:(suppl 2):98-115.
38. Hotham E, Atkinson E, Gilbert A. Focus groups with pregnant smokers: barriers to cessation, attitudes to nicotine patch use and perceptions of cessation counselling by care providers. Drug Alcohol Rev. 2002;21:163-168.
39. Weir B, Stark MJ, Fleming DW, et al. Revealing drug use to prenatal providers: who tells or who is asked? In: Stevens S, Wexler H, eds. Drugs & Society. Philadelphia, PA: The Haworth Press. 1998;161-176.
40. Chasnoff IJ, Neuman K, Thornton C, et al. Screening for substance use in pregnancy: a practical approach for the primary care physician. Am J Obstet Gynecol. 2001;184:752-758.
41. Kerker BD, Horwitz SM, Leventhal JM. Patients' characteristics and providers' attitudes: predictors of screening pregnant women for illicit substance use. Child Abuse Negl. 2004;28:209-223.
42. Tobin M. Lost Opportunity or Lifeline? Women With Substance Use Issues and Their Perceptions of the Barriers to Pregnancy Care. A Report on Research Conducted for the Women's Alcohol & Drug Services. Melbourne: Women's Alcohol and Drug Service, The Royal Women's Hospital1st ed; 2005.
43. Hotham E, White J, Ali R, et al. Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools. J Dev Orig Health Dis. 2012 (In press).
44. Ward C, Mertens J, Flisher AJ, et al. Prevalence and correlates of substance use among South African primary care clinic patients. Subst Use Misuse. 2008; 43:1395-1410.
45. Ndetei D, Khasakhala L, Kuria M, et al. Prevalence of substance abuse among patients in general medical facilities in Kenya. Subst Abuse. 2009;30:182-190.
46. Allen DR, Carey JW, Manopaiboon C, et al. Sexual health risks among young Thai women: implications for HIV/STD prevention and contraception. AIDS Behav. 2003;7:9-21.
47. Holmwood C, Marriott M, Humeniuk R. Substance use patterns in newly admitted male and female South Australian prisoners using the WHO-ASSIST (Alcohol, Smoking and Substance Involvement Screening Test). Int J Prison Health. 2008;4: 198-207.
48. Hides L, Cotton SM, Berger G, et al. The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis. Addict Behav. 2009;34:821-825.
49. Boston University School of Public Health. "Do I have a drug problem?" Questionnaire based on the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) developed by the World Health Organization. Join Together Project. 2009. Available at: http://www.drugscreening.org/. Accessed April 15, 2012.
50. National Institute on Drug Abuse. Screening for Drug Use in General Medical Settings. Adapted from the World HealthOrganization (WHO) Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Version 3.0 2009. February 2, 2009. Available at: http://www.drugabuse.gov/publications/ resourceguide/step-1-nida-modified-assist. Accessed April 15, 2012.
51. Humeniuk R, Holmwood C. Developing the e-ASSIST: The Alcohol, Smoking and Substance Involvement Screening Test Questionnaire in electronic format for Australian clinicians. Drug Alcohol Rev. 2011;30:(suppl 1):41-42.
52. WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97:1183-1194.
53. Humeniuk R, Ali R. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and Pilot Brief Intervention: A WHO technical report of Phase II findings. In Management of Substance Dependence. Geneva: World Health Organization Department of Mental Health and Substance Dependence; 2005.
54. Hotham E, Ali R, White J, et al. Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia. Aust N Z J Obstet Gynaecol. 2008;48:248-254.
55. Chang G, Wilkins-Haug L, Goetz MA, et al. Alcohol use and pregnancy: improving identification. Obstet Gynecol. 1998;91:892-898.
56. Tate JC, Schmitz JM. A proposed revision of the Fagerstrom Tolerance Questionnaire. Addict Behav. 1993;18:135-143.
57. Sobell LC, Sobell MB, Timeline FollowBack A. Technique for assessing self-reported alcohol consumption. In: Litten R, Allen J, eds. Measuring Alcohol Consumption Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press. 1992;41-69.
58. Sobell LC, Sobell MB. Timeline FollowBack User's Guide. Toronto: Addiction Research Foundation; 1996.
59. O'Farrell TJ, Fals-Stewart W, Murphy M. Concurrent validity of a brief self-report drug use frequency measure. Addict Behav. 2003;28:327-337.
60. Duhig AM, Cavallo DA, McKee SA, et al. Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addict Behav. 2005;30: 271-283.
61. Fagerstrom K. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. J Behav Med. 1978;3:235-241.
62. Heatherton T, Kozlowski L, Frecker R, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.
63. Nieburg P, Marks J, McLaren N, et al. The fetal tobacco syndrome. JAMA. 1985;253:2998-2999.
64. Habek D, Habek J, Ivanisevic M, et al. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn Ther. 2002;17:367-371.
65. Klein D, Zahnd E. Perspectives of pregnant substance-using women: findings from the California Perinatal Needs Assessment. J Psychoactive Drugs. 1997;29:55-66.
66. Midanik LT, Zahnd EG, Klein D. Alcohol and drug CAGE screeners for pregnant, low-income women: The California Perinatal Needs Assessment. Alcohol Clin Exp Res. 1998;22:121-125.
67. Huizink A. Moderate use of alcohol, tobacco and cannabis during pregnancy: new approaches and update on research findings. Reprod Toxicol. 2009;28:143-151.
68. Mukherjee RAS, Hollins S, Abou-Saleh MT, et al. Low level alcohol consumption and the fetus. BMJ. 2005;330:375-376.
69. Svikis D, Henningfield J, Gazaway P, et al. Tobacco use for identifying pregnant women at risk of substance abuse. J Reprod Med. 1997;42:299-302.
70. Burns L, Mattick R, Wallace C. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders. Nicotine Tob Res. 2008;10:969-974.
71. Heil SH, Linares Scott T, Higgins ST. An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers. Drug Alcohol Depend. 2009;1045: S106-S114.
72. Quinn VP, Dolan-Mullen P, Ershoff DH. Women who stop smoking spontaneously prior to prenatal care and predictors of relapse before delivery. Addict Behav. 1991;16:29-40.
73. McPherson TL, Hersch RK. Brief substance use screening instruments for primary care settings: A review. J Subst Abuse Treat. 2000;18:193-202.
74. Hunt J, Lumley J. Are recommendations about routine antenatal care in Australia consistent and evidence-based? MJA. 2002;176:255-259.
75. Daley M, Argeriou M, McCarty D. Substance abuse treatment for pregnant women: a window of opportunity? Addict Behav. 1998;23:239-249.
76. Comfort M, Kaltenbach KA. Predictors of treatment outcomes for substance-abusing women: a retrospective study. Subst Abuse. 2000;21:33-45.
77. Jones H, Svikis D, Rosado J, et al. What if they do not want treatment?: lessons learned from intervention studies of non-treatment seeking, drug-using pregnant women. Am J Addict. 2004;13:342-357.
78. Floyd R, Ebrahim S, Tsai J, et al. Strategies to reduce alcohol-exposed pregnancies. Mat Child Health. 2006;10:S149-S151.
79. Gilligan C, Sansom-Fisher R, D'Este C, et al. Knowledge and attitudes regarding smoking during pregnancy among Aboriginal and Torres Strait Islander women. MJA. 2009;190:557-561.
80. Lewis L, Hickey M, Doherty DA, et al. How do pregnancy outcomes differ in teenage mothers? A Western Australian study. MJA. 2009;190:537-541.
81. Miller JWH, Cox SM, Harbison V, et al. Urine drug screens for drug abuse in pregnancy: problems and pitfalls. Womens Health Issues. 1994;4: 152-155.
82. Kandall SR. Substance and Shadow Women and Addiction in the United States. Cambridge, MA. Harvard University Press; 1996.